Paroxetine (Paxil) withdrawal symptoms
Pro Research Analysisby 
Searched over 200M research papers
Paroxetine (Paxil) Withdrawal Symptoms: Key Features and Prevalence
Paroxetine, a selective serotonin reuptake inhibitor (SSRI) with a short half-life, is well known for causing withdrawal symptoms when discontinued, especially if stopped abruptly or without gradual tapering. These symptoms are more common and often more severe with paroxetine compared to other SSRIs due to its pharmacological properties and shorter half-life 245789.
Common Physical and Psychological Withdrawal Symptoms
Withdrawal symptoms from paroxetine typically begin within a few days of stopping the medication and can last from several days to a few weeks, even with gradual tapering 24579. The most frequently reported symptoms include:
- Dizziness and lightheadedness
- Nausea, vomiting, and diarrhea
- Headaches
- Lethargy and fatigue
- Sleep disturbances, such as vivid dreams and insomnia
- Sensory disturbances, including "electric shock" sensations (sometimes called "brain zaps"), tingling, and paresthesia
- Flu-like symptoms, such as muscle aches and chills
- Anxiety, agitation, irritability, and mood swings
- Impaired concentration and memory difficulties 12345678+1 MORE
Distinguishing Withdrawal from Relapse
Withdrawal symptoms can sometimes be mistaken for a return of the original depressive or anxiety disorder, as both can involve mood changes, anxiety, and sleep problems. However, withdrawal symptoms often include new physical sensations (like electric shocks or dizziness) that were not present before treatment, helping to distinguish them from a relapse 457.
Persistent and Severe Postwithdrawal Disorders
In some cases, withdrawal symptoms can persist for months or even years after stopping paroxetine, leading to what are called persistent postwithdrawal disorders. These may include ongoing anxiety, depression, mood swings, insomnia, irritability, and cognitive difficulties. Such symptoms can be severe and disabling, sometimes prompting patients to restart medication 36. Persistent symptoms are more likely with paroxetine than with other SSRIs 356.
Risk Factors and Incidence
The risk of withdrawal symptoms is higher with paroxetine than with other SSRIs, such as fluoxetine, due to its shorter half-life and higher potency for serotonin reuptake inhibition 245789. Symptoms are more likely after longer periods of treatment and with abrupt discontinuation, but can also occur with slow tapering 2579.
Management and Prevention
To minimize withdrawal symptoms, a gradual tapering of paroxetine over several weeks is recommended. In some cases, switching to a longer-acting SSRI like fluoxetine before discontinuation may help reduce symptoms . Cognitive behavioral therapy (CBT) has also been used to help manage persistent postwithdrawal symptoms .
Special Considerations: Neonatal Withdrawal
Neonates exposed to paroxetine in utero may also experience withdrawal symptoms, including jitteriness, vomiting, irritability, hypoglycemia, and, in rare cases, necrotizing enterocolitis. Close monitoring of newborns exposed to paroxetine during pregnancy is advised .
Conclusion
Paroxetine withdrawal is a well-documented phenomenon, with symptoms ranging from mild to severe and, in some cases, long-lasting. The risk is higher with paroxetine than with other SSRIs, making gradual tapering and careful monitoring essential for patients discontinuing this medication. Persistent postwithdrawal symptoms, though less common, can be disabling and may require additional therapeutic support 23456789+1 MORE.
Sources and full results
Most relevant research papers on this topic